(C) Reuters. FILE PHOTO: Newport and Camel cigarettes are stacked on a shelf inside a tobacco store in New York
(Reuters) -The U.S. Food and Drug Administration on Thursday proposed a ban on menthol cigarettes in the United States, a win for anti-tobacco and civil rights groups, but a move that could erase a huge chunk of sales for cigarette manufacturers.
The FDA is working toward issuing proposed product standards within the next year to ban menthol as a flavor in cigarettes and ban all flavors in cigars, the agency said.
The ban is likely to take years to implement amid possible legal challenges from the tobacco industry, which has repeatedly went up against the FDA to try and block anti-tobacco regulation.
The decision comes as the FDA was forced to act by an April 29 court deadline to respond to a 2013 citizen’s petition seeking a ban on menthol cigarettes that activists say Black Americans were the most impacted by the industry’s marketing of the product.
“Banning menthol – the last allowable flavor – in cigarettes and banning all flavors in cigars will help save lives, particularly among those disproportionately affected by these deadly products,” Acting FDA Commissioner Janet Woodcock said in a statement. (https://
According to a Bernstein research estimate, British American Tobacco (NYSE:BTI) Plc generates 55% of its cigarette volumes in the United States from menthols, led by its Newport brand, compared with 30% for Imperial Brands (OTC:IMBBY) Plc and 17% for Altria Group (NYSE:MO) Inc .
Shares of Altria, BATS and Imperial Brands were down about 1% after the FDA announcement
U.S. FDA proposes ban on menthol cigarettes, faces challenges
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.